CC
TGX

Cannell Capital’s THERAGENICS CORP TGX Stock Holding History

Cannell Capital’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-364,107
Closed -$794K – 82
2013
Q3 		$794K Sell
364,107
-367,293
-50% -$783K 0.39% 45
2013
Q2 		$1.51M Buy
+731,400
New +$1.31M 0.9% 36

Cannell Capital's TGX Position: Q4 2013 in Review

Cannell Capital sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 364,107 shares — an estimated $794K sold.

Cannell Capital first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $1.51M in Q2 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Cannell Capital reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Cannell Capital sold 364,107 THERAGENICS CORP shares in Q4 2013, an estimated $794K.
  • Cannell Capital first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • Cannell Capital's THERAGENICS CORP position peaked at $1.51M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Cannell Capital's 13F filing for Q4 2013, filed 14 Feb 2014.